Investigating the optimal size of anticancer nanomedicine.

导出 OA

翻译打印收藏纠错

作者： Li,Tang ^[1] ; Xujuan,Yang ^[2] ; Qian,Yin ^[1] ; Kaimin,Cai ^[1] ; Hua,Wang ^[1] ; Isthier,Chaudhury ^[1] ; Catherine,Yao ^[1] ; Qin,Zhou ^[3] ; Mincheol,Kwon ^[1] ; James A,Hartman ^[2] ; Iwona T,Dobrucki ^[4] ; Lawrence W,Dobrucki ^[5] ; Luke B,Borst ^[6] ; Stéphane,Lezmi ^[7] ; William G,Helferich ^[8] ; Andrew L,Ferguson ^[9] ; Timothy M,Fan ^[10] ; Jianjun,Cheng ^[11]

作者单位： Departments of Materials Science and Engineering. ^[1] Food Science and Human Nutrition. ^[2] Department of Pharmaceutical Science, Guangdong Pharmaceutical College, Guangzhou, Guangdong, 510006, China; and. ^[3] Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801; ^[4] Bioengineering. ^[5] Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC 27606. ^[6] Pathobiology, and. ^[7] Food Science and Human Nutrition, jianjunc@illinois.edu t-fan@illinois.edu alf@illinois.edu helferic@illinois.edu. ^[8] Departments of Materials Science and Engineering, jianjunc@illinois.edu t-fan@illinois.edu alf@illinois.edu helferic@illinois.edu. ^[9] Veterinary Clinical Medicine, and jianjunc@illinois.edu t-fan@illinois.edu alf@illinois.edu helferic@illinois.edu. ^[10] Departments of Materials Science and Engineering, Bioengineering, jianjunc@illinois.edu t-fan@illinois.edu alf@illinois.edu helferic@illinois.edu. ^[11]

关键词 drug delivery mathematical model nanomedicine silica nanoparticle size effect